<DOC>
	<DOCNO>NCT00547274</DOCNO>
	<brief_summary>The purpose study compare lipid-altering effect MK0767 , glipizide , pioglitazone 12 week treatment . This early phase trial specific protocol information progress publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>Dyslipidemia Type 2 Diabetes ( 0767-034 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Men nonpregnant female Age great equal 21 year Stop current diabetes therapy ( applicable ) Stop current statin therapy ( applicable ) History type 1 diabetes mellitus ketoacidosis currently treat insulin Patients weight loss program ongoing weight loss , start intensive exercise program within last four week Patients require treatment corticosteroid 14 consecutive day Patients take warfarin warfarinlike anticoagulant Patients undergo surgery within 30 day Visit 1 Patients Hepatitis B , Hepatitis C , active liver gallbladder disease Patients history pancreatitis uncontrolled high blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>